Skip to main content

Table 1 Relevant studies of acute treatment headache response at 15 or 30 min

From: Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions

Trial and Year

Placebo

Suma SC

Zolmi NS

O2 low

O2 high

Suma NS

Headache Response Timeline Analyzed

Ekbom 1991 [21]

25%, n = 39

74%, n = 39

    

15 min

Ekbom 1993 [20]

35%, n = 88

75%, n = 93

    

15 min

Cittadini 2006 [24]

23%, n = 61

 

42%, n = 65

   

30 min

Rapoport 2007 [22]

30%, n = 59

 

50%, n = 52

   

30 min

Fogan 1985 [27]

33%, n = 63

  

68%, n = 74

  

15 min

Cohen 2009 [26]

20%, n = 148

   

78%, n = 150

 

15 min

Dirkx 2018 [9]

   

14%, n = 14

33%, n = 15

 

15 min

Van Viet 2003 [23]

26%, n = 77

    

57%, n = 77

30 min

  1. Used with permission from Medrea et al., Headache 2022 [19]
  2. O 2 oxygen, SC subcutaneous, nVNS non-invasive vagal nerve stimulation, NS nasal spray, Suma sumatriptan; Zolmi, zolmitriptan